Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VESPA 2.0 - Virtual Environment for a Superior Neuropsychiatry Second Generation

NCT06281314 is registered in ClinicalTrials.gov with IRCCS Centro Neurolesi Bonino Pulejo as lead sponsor.

NCT NCT06281314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06281314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VESPA 2.0 - Virtual Environment for a Superior Neuropsychiatry Second Generation
Lead sponsor
IRCCS Centro Neurolesi Bonino Pulejo
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2021
Completion date
December 31, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive decline, multiple sclerosis, neurodegenerative diseases, parkinson disease dementia